Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
IGE-H82E3 | Human | Biotinylated Human IgE Fc Protein, His,Avitag™ | ![]() |
![]() ![]() |
|
IGE-M52H3 | Mouse | Mouse IgE Fc Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
IGE-C52H3 | Cynomolgus | Cynomolgus IgE Fc Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
IGE-H52H9 | Human | Human IgE Fc Protein, His Tag | ![]() |
![]() ![]() |
Human Fc epsilon RI alpha, His Tag (Cat. No. FCA-H5228) immobilized on CM5 Chip can bind Mouse IgE Fc Protein, His Tag (Cat. No. IGE-M52H3) with an affinity constant of 0.391 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Omalizumab biosimilar (IBC Generium) | GNR-044 | Approved | Ibc Generium | Genolair | Russian Federation | Asthma; Chronic Urticaria | Generium Pharmaceuticals | 2022-02-09 | Chronic Urticaria; Asthma | Details |
Omalizumab biosimilar (Mabtech) | STI-004; CMAB007; CMAB-007 | Approved | Shanghai Zhangjiang Biotechnology Co Ltd | Aomaishu, 奥迈舒 | Mainland China | Asthma | Taizhou Mabtech Pharmaceutical Co Ltd | 2023-05-19 | Chronic Urticaria; Allergic asthma; Asthma | Details |
Omalizumab biosimilar (Synermore Biologics) | SYN-008 | Approved | Cspc Baike (Shandong) Biopharmaceutical Co Ltd, Synermore Biologics (Suzhou) Co Ltd | Mainland China | Chronic Urticaria | Jushi Biopharmaceutical Co Ltd | 2024-09-26 | Chronic Urticaria | Details | |
Omalizumab biosimilar(Celltrion) | CT-P39 | Approved | Celltrion Inc | Omlyclo | EU | Allergic asthma; Sinusitis | Celltrion Healthcare Hungary Kft | 2024-05-16 | Chronic Urticaria; Allergic asthma; Food Hypersensitivity; Sinusitis; Asthma | Details |
Omalizumab | GN-1560; RG-3648; IGE-025A; rhuMAb-E25; R-3648; E-25; IGE-025 | Approved | Novartis Pharma Ag, Genentech Inc | Xolair, 茁乐 | Australia | Asthma; Chronic Urticaria | null | 2002-01-01 | Job Syndrome; Gastroenteritis; Rhinitis; Mastocytosis; Dermatitis, Atopic; Angioedema; Hypersensitivity; Infertility, Female; Pulmonary Disease, Chronic Obstructive; Peanut Hypersensitivity; Bronchitis; Pemphigoid, Bullous; Asthma; Urticaria; Esophagitis; Sinusitis; Respiratory Tract Infections; Eosinophilic Esophagitis; Lupus Erythematosus, Systemic; Allergic asthma; Food Hypersensitivity; Immune System Diseases; Milk Hypersensitivity; Sjogren's Syndrome; Colonic Neoplasms; Nasal Polyps; Coronavirus Disease 2019 (COVID-19); Chronic Urticaria; Autism Spectrum Disorder; Anaphylaxis; Drug Hypersensitivity; Rhinitis, Allergic, Seasonal | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Omalizumab biosimilar (Reliance Life Sciences) | R-TPR-022 | Phase 3 Clinical | Reliance Life Sciences | Asthma | Details |
Omalizumab biosimilar (Teva) | TEV-45779 | Phase 3 Clinical | Teva Pharmaceutical Industries Ltd | Chronic Urticaria | Details |
Ligelizumab | QGE-031 | Phase 3 Clinical | Genentech Inc | Chronic Urticaria; Food Hypersensitivity; Asthma; Pemphigoid, Bullous; Urticaria; Peanut Hypersensitivity; Hypersensitivity; Dermatitis, Atopic | Details |
Omalizumab biosimilar (Curateq Biologics) | BP11; BP-11 | Phase 3 Clinical | CuraTeQ Biologics Pvt Ltd | Chronic Urticaria | Details |
Omalizumab biosimilar (BiosanaPharma) | ADL-018; AVT-23; BP-001 | Phase 3 Clinical | BiosanaPharma BV | Chronic Urticaria; Allergic asthma | Details |
LP-003 (Tianchen Biomedical) | LP-003 | Phase 3 Clinical | Longbio Pharma (Suzhou) Co Ltd | Rhinitis, Allergic, Seasonal; Chronic Urticaria; Nasal Polyps; Rhinitis, Allergic; Food Hypersensitivity; Allergic asthma; Asthma; Sinusitis | Details |
Recombinant anti-IgE monoclonal antibody(Cspc Baike) | Phase 3 Clinical | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | Chronic Urticaria; Asthma | Details | |
Anti-CEmX monoclonal antibody (Fountain Biopharma) | h4B12; FB-825 | Phase 2 Clinical | Academia Sinica | Asthma; Dermatitis, Atopic | Details |
UB-221 | UB-221 | Phase 2 Clinical | Chinese Academy Of Sciences | Chronic Urticaria | Details |
Omalizumab biosimilar (Glenmark) | GBR-310 | Phase 2 Clinical | Glenmark Pharmaceuticals Ltd | Chronic Urticaria; Asthma | Details |
Bifidobacterium Bifidum(Sun Yat-sen University) | Phase 2 Clinical | Sun Yat-Sen University | Carcinoma, Hepatocellular | Details | |
RPT-904 | RPT-904; JYB-1904 | Phase 2 Clinical | Jiangsu Jiye Biopharmaceutical Co Ltd | Chronic Urticaria; Allergic asthma; Asthma; Urticaria | Details |
ADP-101 | ADP-101 | Phase 2 Clinical | Alladapt Immunotherapeutics Inc | Food Hypersensitivity | Details |
Omalizumab biosimilar (Hisun BioRay) | HS632; HS-632 | Phase 1 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Asthma | Details |
Omalizumab biosimilar (Fountain BioPharma) | FB-317 | Phase 1 Clinical | Academia Sinica | Asthma; Urticaria | Details |
Omalizumab biosimilar(Yuhan) | YH-35324 | Phase 1 Clinical | Yuhan Corp | Chronic Urticaria; Immune System Diseases; Urticaria; Hypersensitivity | Details |
IGNX-001 | IGNX-001; IGNX001; IGX-0107 and IGX-0109 | Phase 1 Clinical | IgGenix Inc | Peanut Hypersensitivity | Details |
Omalizumab biosimilar (Tianchen Biomedical) | Phase 1 Clinical | Longbio Pharma (Suzhou) Co Ltd | Chronic Urticaria | Details | |
Anti-IgE allergy vaccine (United Biomedical) | Phase 1 Clinical | United Biomedical Inc | Hypersensitivity | Details |
This web search service is supported by Google Inc.